Merkel Positron Emission Tomography (PET) Protocol

NCT01013779 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Merkel Cell Carcinoma

Interventions

DRUG: Carboplatin
DRUG: Etoposide
RADIATION: Radiotherapy

Sponsor

Trans Tasman Radiation Oncology Group